This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

T Regulatory and Childhood Asthma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00204828
First received: September 12, 2005
Last updated: June 28, 2017
Last verified: June 2017
  Purpose
This is an epidemiologic study, examining environmental exposures and affect on immune development.

Condition
Childhood Asthma

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Prospective
Official Title: T Regulatory and Childhood Asthma

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Childhood asthma [ Time Frame: 3 years ]
  • Allergic sensitization [ Time Frame: 3 years ]

Biospecimen Retention:   Samples Without DNA
blood, PBMC culture supes and nasal lavage

Enrollment: 58
Study Start Date: October 2005
Estimated Study Completion Date: December 2017
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
1.
Children with asthma
2.
Children without asthma

Detailed Description:
This is an epidemiologic study, examining environmental exposures and affect on immune development. The study has completed enrollment
  Eligibility

Ages Eligible for Study:   6 Years to 7 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
6-7 yo children of either gender
Criteria

Inclusion Criteria:

  • moderate to severe asthma

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00204828

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: James Gern, MD University of Wisconsin, Madison
  More Information

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00204828     History of Changes
Other Study ID Numbers: H-2004-0224
R01HL080072 ( U.S. NIH Grant/Contract )
Study First Received: September 12, 2005
Last Updated: June 28, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 25, 2017